This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Publicly held cancer companies TopoTarget AS and BioAlliance Pharma SA entered into a merger agreement that will culminate with TopoTarget operating as a wholly owned BioAlliance subsidiary, owning approximately 1/3 of the combined entity’s stock. For every 27 shares held, TopoTarget stockholders get two BioAlliance shares. Based on the pre-announcement market average, the deal is worth €83.4mm ($115mm).
Payment Includes Stock
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?